Botulinum toxin A for treatment of sialorrhea in children: An effective, minimally invasive approach

Archives of Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 4, 2011, Pages 339-344

  Khan, Waqas Ullah ^a   Campisi, Paolo ^b   Nadarajah, Sanjeevan ^b   Shakur, Yaseer Abdul ^a   Khan, Nasir ^a   Semenuk, Dan ^c   McCann, Cathy ^c   Roske, Lisa ^c   McConney Ellis, Sharon ^c   Joseph, Melissa ^c   Parra, Dimitri ^b   Amaral, Joao ^b   John, Philip ^b   Temple, Michael ^b   Connolly, Bairbre ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c HOLLAND BLOORVIEW KIDS REHABILITATION HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

AGE DISTRIBUTION; ARTICLE; ASPIRATION PNEUMONIA; CANADA; CAREGIVER SUPPORT; CEREBRAL PALSY; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DYSPHAGIA; DYSPHONIA; ECHOGRAPHY; FEMALE; GENERAL ANESTHESIA; HEAD BANGING; HUMAN; HYPERSALIVATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; NAUSEA; NEUROLOGIC DISEASE; PAIN; PEDIATRIC HOSPITAL; PEDIATRIC REHABILITATION; QUALITY OF LIFE; RATING SCALE; RETROSPECTIVE STUDY; SALIVA ANALYSIS; SALIVA CONSISTENCY; SATISFACTION; SEDATION; SEX RATIO; SPEECH DISORDER; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING; XEROSTOMIA;

BOTULINUM TOXINS, TYPE A; CHILD; FEMALE; HUMANS; INJECTIONS; LINEAR MODELS; MALE; NERVOUS SYSTEM DISEASES; NEUROMUSCULAR AGENTS; ONTARIO; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SAFETY; SIALORRHEA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 79954462494     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2010.240     Document Type: Article

References (29)

1. Tan EK. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations. Eur J Neurol. 2006;13(suppl 1):60-64.
2. Lim M, Mace A, Nouraei SA, Sandhu G. Botulinum toxin in the management of sialorrhoea: a systematic review. Clin Otolaryngol. 2006;31(4):267-272. (Pubitemid 44141089)
3. Hockstein NG, Samadi DS, Gendron K, Handler SD. Sialorrhea: a management challenge. Am Fam Physician. 2004;69(11):2628-2634. (Pubitemid 38720449)
4. Lal D, Hotaling AJ. Drooling. Curr Opin Otolaryngol Head Neck Surg. 2006;14(6):381-386.
5. Bothwell JE, Clarke K, Dooley JM, et al. Botulinum toxin A as a treatment for excessive drooling in children. Pediatr Neurol. 2002;27(1):18-22. (Pubitemid 34826569)
6. Suskind DL, Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope. 2002;112(1):73-81. (Pubitemid 34037741)
7. Benson J, Daugherty KK. Botulinum toxin A in the treatment of sialorrhea. Ann Pharmacother. 2007;41(1):79-85. (Pubitemid 46145960)
8. Bushara KO. Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment - botulinum toxin A injections of the parotid glands. Med Hypotheses. 1997;48(4):337-339. (Pubitemid 27224159)
9. Proulx M, de Courval FP, Wiseman MA, Panisset M. Salivary production in Parkinson's disease. Mov Disord. 2005;20(2):204-207. (Pubitemid 40361124)
10. Gerlinger I, Szalai G, Hollódy K, Németh A. Ultrasound-guided, intraglandular injection of botulinum toxin A in children suffering from excessive salivation. J Laryngol Otol. 2007;121(10):947-951. (Pubitemid 351650448)
11. Savarese R, Diamond M, Elovic E, Millis SR. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy. Am J Phys Med Rehabil. 2004;83(4):304-311, quiz 312-314, 336.
12. Shetty S, Dawes P, Ruske D, Al-qudah M, Lyons B. Botulinum toxin type-A (Botox-A) injections for treatment of sialorrhoea in adults: a New Zealand study. N Z Med J. 2006;119(1240):U2129.
13. Banerjee KJ, Glasson C, O'Flaherty SJ. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy. Dev Med Child Neurol. 2006;48(11):883-887. (Pubitemid 44596980)
14. Meningaud JP, Pitak-Arnnop P, Chikhani L, Bertrand JC. Drooling of saliva: a review of the etiology and management options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(1):48-57. (Pubitemid 41797038)
15. Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(9, pt 2):S199-S202.
16. Alrefai AH, Aburahma SK, Khader YS. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial. Clin Neurol Neurosurg. 2009;111(1):79-82.
17. Reid SM, Johnstone BR, Westbury C, Rawicki B, Reddihough DS. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders. Dev Med Child Neurol. 2008;50(2):123-128. (Pubitemid 351972027)
18. Kim H, Lee Y, Weiner D, Kaye R, Cahill AM, Yudkoff M. Botulinum toxin type a injections to salivary glands: combination with single event multilevel chemoneurolysis in 2 children with severe spastic quadriplegic cerebral palsy. Arch Phys Med Rehabil. 2006;87(1):141-144. (Pubitemid 43053319)
19. Hassin-Baer S, Scheuer E, Buchman AS, Jacobson I, Ben-Zeev B. Botulinum toxin injections for children with excessive drooling. J Child Neurol. 2005;20(2):120-123. (Pubitemid 40484851)
20. Jongerius PH, Rotteveel JJ, van Limbeek J, Gabreëls FJ, van Hulst K, van den Hoogen FJ. Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology. 2004;63(8):1371-1375. (Pubitemid 39426267)
21. Jongerius PH, Joosten F, Hoogen FJ, Gabreels FJ, Rotteveel JJ. The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glands. Laryngoscope. 2003;113(1):107-111. (Pubitemid 36050523)
22. Jongerius PH, Rotteveel JJ, van den Hoogen F, Joosten F, van Hulst K, Gabreëls FJ. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series. Eur J Pediatr. 2001;160(8):509-512. (Pubitemid 32695833)
23. Berweck S, Schroeder AS, Lee SH, Bigalke H, Heinen F. Secondary non-response due to antibody formation in a child after three injections of botulinum toxin B into the salivary glands. Dev Med Child Neurol. 2007;49(1):62-64. (Pubitemid 46332043)
24. Herrmann J, Geth K, Mall V, et al. Clinical impact of antibody formation to botulinum toxin A in children. Ann Neurol. 2004;55(5):732-735. (Pubitemid 38544335)
25. Linder-Lucht M, Kirschner J, Herrmann J, et al. "Why do children with cerebral palsy discontinue therapy with botulinum toxin A?" Dev Med Child Neurol. 2006;48(4):319-320.
26. Laing TA, Laing ME, O'Sullivan ST. Botulinum toxin for treatment of glandular hypersecretory disorders. J Plast Reconstr Aesthet Surg. 2008;61(9):1024-1028.
27. Fuster Torres MA, Berini Aytés L, Gay Escoda C. Salivary gland application of botulinum toxin for the treatment of sialorrhea. Med Oral Patol Oral Cir Bucal. 2007;12(7):E511-E517.
28. Khan A, Pawar G. The use of botulinum toxic injection to treat excessive drooling in children with neurological conditions. W V Med J. 2005;101(6):258-260.
29. Wilken B, Aslami B, Backes H. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B. Neuropediatrics. 2008;39(4):200-204.